Experts Developing Way to Harness Nobel Prize Winning CRISPR Technology to Deal with Antimicrobial Resistance (AMR)

Antimicrobial resistance (AMR) is continuing to increase globally, with rates of AMR in most pathogens increasing and threatening a future in which every-day medical procedures may no longer be possible and infections thought long dealt with could kill regularly again. As such, new tools to battle AMR are vitally needed. In a new research review at this year’s ESCMID Global Congress (formerly ECCMID – Barcelona 27-30 April) shows how the latest CRISPR-Cas gene editing technology can be used to help modify and attack AMR bacteria. The presentation is by Dr. Rodrigo Ibarra-Chávez, Department of Biology, University of Copenhagen, Denmark.

Login Or Register To Read Full Story